Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **T cell receptor beta variable 6** (**TRBV6**) is one member of a family of gene segments encoding the variable region of the β chain in αβ T cell receptors. The **T cell receptor** is a heterodimeric membrane-bound protein complex found on most mature T lymphocytes. It consists typically of an alpha and a beta chain, each with highly diverse variable regions generated through somatic recombination involving multiple gene segments—variable (**V**), diversity (**D**, only for β), and joining (**J**)—and random nucleotide insertions/deletions at their junctions. The **Vβ6** designation refers specifically to one subgroup within the large set (~48) of human β-chain variable region genes. The primary function of any given **TCR β-chain**, including those encoded by TRBV6, is to contribute to antigen specificity by forming part of the antigen-binding site that recognizes peptide fragments presented by major histocompatibility complex molecules on other cells. The complementarity-determining region 3 (**CDR3**) within this domain is especially important for determining binding specificity due to its high sequence variability resulting from recombination events. While there are no approved drugs that specifically target or modulate individual Vβ families such as TRBV6, understanding their distribution can be important in research settings—for example, tracking clonal expansions during infection or cancer immunotherapy. Engineered cellular therapies may utilize defined Vα/Vβ combinations for targeted recognition. In summary, **T cell receptor beta variable 6** is an essential component contributing to antigen recognition diversity among αβ T cells—a key element enabling adaptive immunity's breadth and specificity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T cell receptor beta variable 6 (TRBV6) (TRBV6).